Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Kitamura, Naohito ^a   Araya, Runa ^a   Kudoh, Moeko ^a   Kishida, Haruo ^a   Kimura, Tetsuya ^a   Murayama, Miyuki ^a   Takashima, Akihiko ^a   Sakamaki, Yuriko ^a   Hashikawa, Tsutomu ^a   Ito, Shingo ^b   Ohtsuki, Sumio ^b   Terasaki, Tetsuya ^b   Wess, Jürgen ^c   Yamada, Masahisa ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M5 RECEPTOR; NITRIC OXIDE; PROTEIN GPR30; UNCLASSIFIED DRUG; BETHANECHOL; ESTROGEN; ESTROGEN RECEPTOR; GPR30 PROTEIN, MOUSE; MUSCARINIC AGENT; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BASILAR ARTERY; BRAIN ATROPHY; BRAIN CORTEX; CELL IMMORTALIZATION; CELL SWELLING; CEREBROVASCULAR ACCIDENT; COGNITION; CONTROLLED STUDY; DENDRITE; DRUG EFFICACY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME RELEASE; FEMALE; HIPPOCAMPUS; IMAGE RECONSTRUCTION; IN VIVO STUDY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PHENOTYPE; SEX DIFFERENCE; SYNAPSE; THREE DIMENSIONAL IMAGING; ANIMAL; BLOOD FLOW; BRAIN; BRAIN CIRCULATION; CELL LINE; CEREBROVASCULAR DISEASE; CYTOLOGY; DISEASE MODEL; DRUG POTENTIATION; GENETICS; HISTOLOGY; HUMAN; METABOLISM; MOUSE MUTANT; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

MUS;

ANIMALS; BASILAR ARTERY; BETHANECHOL; BRAIN; CELL LINE; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; NEURONS; NEUROPSYCHOLOGICAL TESTS; NITRIC OXIDE; OVARIECTOMY; PHENOTYPE; RECEPTOR, MUSCARINIC M5; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; REGIONAL BLOOD FLOW; SEX CHARACTERISTICS; SODIUM-HYDROGEN ANTIPORTER;

EID: 65249104536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005159     Document Type: Article

References (62)

1. Faraci FM, Sigmund CD (1999) Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res 85: 1214-1225.
2. Hotta H, Uchida S, Kagitani F (2002) Effects of stimulating the nucleus basalis of Meynert on blood flow and delayed neuronal death following transient ischemia in the rat cerebral cortex. Jpn J Physiol 52: 383-393.
3. Sato A, Sato Y, Uchida S (2004) Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus. Neurosci Lett 361: 90-93.
4. Furchgott RF, Zawadzki J V (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
5. Rosenblum WI (1986) Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 17: 494-497.
6. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
7. Meng W, Ma J, Ayata C, Hara H, Huang PL, et al. (1996) ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol 271: H1145-H1150.
8. Sobey CG, Faraci FM (1997) Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28: 837-842.
9. 5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 98: 14096-14101.
10. Tayebati SK, Di Tullio MA, Tomassoni D, Amenta F (2003) Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries. Neuroscience 122: 205-211.
11. Hamel E (2004) Cholinergic modulation of the cortical microvascular bed. Prog Brain Res 145: 171-178.
12. Wang SZ, Zhu SZ, el-Fakahany EE (1994) Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J Pharmacol Exp Ther 268: 552-557.
13. Bonner TI, Young AC, Brann MR, Buckley NJ (1988) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Neuron 1: 403-410.
14. Liao CF, Themmen AP, Joho R, Barberis C, Birnbaumer M, et al. (1989) Molecular cloning and expression of a fifth muscarinic acetylcholine receptor. J Biol Chem 264: 7328-7337.
15. Reever CM, Ferrari-DiLeo G, Flynn DD (1997) The M5 (m5) receptor subtype: fact or fiction? Life Sci 60: 1105-1112.
16. 5 receptor: A silent or emerging subtype? Br J Pharmacol 130: 13-21.
17. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, et al. (2006) Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 24: 334-344.
18. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35: 2598-603.
19. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, et al. (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38: 2826-2832.
20. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, et al. (2000) Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682.
21. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, et al. (1999) Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406.
22. Zivadinovic D, Watson CS (2005) Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7: R130-R144.
23. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, et al. (2006) The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 20: 631-646.
24. Oishi A, Ohmichi M, Takahashi K, Takahashi T, Mori-Abe A, et al. (2004) Medroxyprogesterone acetate attenuates estrogen-induced nitric oxide production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 324: 193-198.
25. Guo X, Razandi M, Pedram A, Kassab G, Levin ER (2005) Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 280: 19704-19710.
26. Kim JK, Levin ER (2006) Estrogen signaling in the cardiovascular system. Nucl Recept Signal 4: e013.
27. Xia Y, Krukoff TL (2004) Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells. Endocrinology 145: 4550-4557.
28. Ohtsuki S, Tachikawa M, Takanaga H, Shimizu H, Watanabe M, et al. (2002) The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J Cereb Blood Flow Metab 22: 1327-1335.
29. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, et al. (2008) Estrogen Signaling through the Transmembrane G Protein-Coupled Receptor GPR30 Annu Rev Physiol 70: 165-190.
30. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, et al. (2007) Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49: 1358-1363.
31. Grossini E, Molinari C, Mary DA, Uberti F, Caimmi PP, et al. (2008) Intracoronary genistein acutely increases coronary blood flow in anesthetized pigs through β-adrenergic mediated nitric oxide release and estrogenic receptors. Endocrinology 149: 2678-2687.
32. Khurana S, Yamada M, Wess J, Kennedy RH, Raufman JP (2005) Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M3 receptor-dependent. Eur J Pharmacol 517: 103-110.
33. Lamping KG, Wess J, Cui Y, Nuno DW, Faraci FM (2004) Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine. Arterioscler Thromb Vasc Biol 24: 1253-1258.
34. Gao X, Dluzen DE (2001) Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience 103: 385-394.
35. Mellergard YB, Ouyang BK, Siesjo (1993) Intracellular pH regulation in cultured rat astrocytes in CO2/HCO3(-)-containing media. Exp. Brain Res 95: 371-380.
36. Jung YW, Choi IJ, Kwon TH (2007) Altered expression of sodium transporters in ischemic penumbra after focal cerebral ischemia in rats. Neurosci Res 59: 152-159.
37. Dodel RC, Du Y, Bales KR, Gao F, Paul SM (1999) Sodium salicylate and 17β-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid Aβ (1-40) and lipopolysaccharides. J Neurochem 73: 1453-1460.
38. Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, et al. (1999) Estrogen and microglia: A regulatory system that affects the brain. J Neurobiol 40: 484-496.
39. Saria A, Lundberg JM (1983) Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 8: 41-49.
40. Yang SH, Shi J, Day AL, Simpkins JW (2000) Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 31: 745-749.
41. McCullough LD, Alkayed NJ, Traystman RJ, Williams MJ, Hurn PD (2001) Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 32: 796-802.
42. Yong Y, Xie HJ, Zhang YF, Yang QD, Liao DF, et al. (2005) 17beta-estradiol potentiates ischemia-reperfusion injury in diabetic ovariectomized female rats. Brain Res 1054: 192-199.
43. Santizo RA, Anderson S, Ye S, Koenig HM, Pelligrino DA (2000) Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke 9: 2231-2235.
44. Jia J, Guan D, Zhu W, Alkayed NJ, Wang MM, et al. (2009) Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp Neurol 215: 48-52.
45. Karas RH, Patterson BL, Mendelsohn ME (1994) Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89: 1943-1950.
46. Kim-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, et al. (1996) Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94: 1402-1407.
47. Chambliss KL, Shaul PW (2002) Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23: 665-686.
48. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER (2004) Plasma membrane estrogen receptors exist and functions as dimmers. Mol Endocrinol 18: 2854-2865.
49. Syková E, Mazel T, Hasenöhrl RU, Harvey AR, Simonová Z, et al. (2002) Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus. Hippocampus 12: 269-279.
50. Rehncrona S (1985) Brain acidosis. Ann Emerg Med 14: 770-776.
51. Yao H, Ginsberg MD, Eveleth DD, LaManna JC, Watson BD, et al. (1995) Local cerebral glucose utilization and cytoskeletal proteolysis as indices of evolving focal ischemic injury in core and penumbra. J Cereb Blood Flow Metab 15: 398-408.
52. Orlowski J, Grinstein S (2004) Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch 447: 549-565.
53. Ma E, Haddad GG (1997) Expression and localization of Na+/H+ exchangers in rat central nervous system. Neuroscience 79: 591-603.
54. Slezak M, Pfrieger FW (2003) New roles for astrocytes: regulation of CNS synaptogenesis. Trends Neurosci 26: 531-535.
55. Wang X, Lou N, Xu Q, Tian GF, Peng WG, et al. (2006) Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo. Nat Neurosci 9: 816-823.
56. Haydon PG (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2: 185-193.
57. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001) Control of synapse number by glia. Science 291: 657-660.
58. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14: 7680-7687.
59. Green PS, Bishop J, Simpkins JW (1997) 17 β-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17: 511-515.
60. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, et al. (2001) Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98: 1952-1957.
61. Hosoya K, Tetsuka K, Nagase K, Tomi M, Saeki S, et al. (2000) Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene. AAPS PharmSci 2: E27.
62. Cooney JR, Hurlburt JL, Selig DK, Harris KM, Fiala JC (2002) Endosomal compartments serve multiple hippocampal dendritic spines from a widespread rather than a local store of recycling membrane. J Neurosci 22: 2215-2224.